Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. THC
stocks logo

THC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
5.47B
+7.76%
4.016
+16.75%
5.45B
+4.32%
4.420
+1.38%
5.50B
+4.34%
4.076
+1.39%
Estimates Revision
The market is revising Upward the revenue expectations for Tenet Healthcare Corporation (THC) for FY2025, with the revenue forecasts being adjusted by 0.44% over the past three months. During the same period, the stock price has changed by 8.14%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.44%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+1.46%
In Past 3 Month
Stock Price
Go Up
up Image
+8.14%
In Past 3 Month
Wall Street analysts forecast THC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THC is 236.24 USD with a low forecast of 190.00 USD and a high forecast of 260.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Analyst Rating
Wall Street analysts forecast THC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THC is 236.24 USD with a low forecast of 190.00 USD and a high forecast of 260.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Buy
0 Hold
0 Sell
Strong Buy
Current: 212.140
sliders
Low
190.00
Averages
236.24
High
260.00
Current: 212.140
sliders
Low
190.00
Averages
236.24
High
260.00
Guggenheim
Buy
upgrade
$238 -> $257
2025-12-02
New
Reason
Guggenheim
Price Target
$238 -> $257
2025-12-02
New
upgrade
Buy
Reason
Guggenheim raised the firm's price target on Tenet Healthcare to $257 from $238 and keeps a Buy rating on the shares.
Barclays
Andrew Mok
Overweight
maintain
$229 -> $240
2025-11-21
Reason
Barclays
Andrew Mok
Price Target
$229 -> $240
2025-11-21
maintain
Overweight
Reason
Barclays analyst Andrew Mok raised the firm's price target on Tenet Healthcare to $240 from $229 and keeps an Overweight rating on the shares. The firm says employer-sponsored insurance coverage looks under pressure but will be "potentially masked" by positive Affordable Care Act trends benefiting hospitals.
Wells Fargo
Overweight
maintain
$238 -> $252
2025-11-13
Reason
Wells Fargo
Price Target
$238 -> $252
2025-11-13
maintain
Overweight
Reason
Wells Fargo raised the firm's price target on Tenet Healthcare to $252 from $238 and keeps an Overweight rating on the shares following quarterly results. Overall, modestly higher EBITDA estimates and rolling fully to 2027 estimates offsets a material increase in the odds of enhanced exchange subsidies expiring in the firm's price target framework, Wells says.
JPMorgan
NULL -> Overweight
maintain
$200 -> $230
2025-11-13
Reason
JPMorgan
Price Target
$200 -> $230
2025-11-13
maintain
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Tenet Healthcare to $230 from $200 and keeps an Overweight rating on the shares. The firm updated the company's model.
Mizuho
Ann Hynes
maintain
$225 -> $235
2025-11-03
Reason
Mizuho
Ann Hynes
Price Target
$225 -> $235
2025-11-03
maintain
Reason
Mizuho analyst Ann Hynes raised the firm's price target on Tenet Healthcare to $235 from $225 and keeps an Outperform rating on the shares. The company reported strong Q3 results and continues to benefit from solid underlying demand trends, the analyst tells investors in a research note.
Truist
Buy
maintain
$225 -> $240
2025-11-03
Reason
Truist
Price Target
$225 -> $240
2025-11-03
maintain
Buy
Reason
Truist raised the firm's price target on Tenet Healthcare to $240 from $225 and keeps a Buy rating on the shares. The firm is updating its model after the company's Q3 earnings beat and guidance raise, the analyst tells investors in a research note.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Tenet Healthcare Corp (THC.N) is 12.99, compared to its 5-year average forward P/E of 11.65. For a more detailed relative valuation and DCF analysis to assess Tenet Healthcare Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
11.65
Current PE
12.99
Overvalued PE
13.77
Undervalued PE
9.52

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
7.09
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
7.53
Undervalued EV/EBITDA
6.66

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.46
Current PS
0.00
Overvalued PS
0.63
Undervalued PS
0.28
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areSelling! The selling amount has increased 1492.05% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 337.36% over the last quarter.
Sold
Bought
Congress Trading
Congress areBuying! The buying amount has increased100%over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 1492.05% over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

THC News & Events

Events Timeline

(ET)
2025-10-28
06:49:23
Tenet Healthcare projects FY25 adjusted EPS between $15.93 and $16.26, surpassing consensus estimate of $15.83.
select
2025-10-28
06:47:55
Tenet Healthcare announces Q3 adjusted earnings per share of $3.70, surpassing consensus estimate of $3.35.
select
2025-10-27 (ET)
2025-10-27
20:25:00
Key companies set to report earnings before tomorrow's market opening
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-27NASDAQ.COM
Tenet (THC) Rises 4% Since Previous Earnings Report: Will the Momentum Last?

  • Earnings Performance: Tenet Healthcare reported Q3 2025 adjusted EPS of $3.70, exceeding estimates by 11.1%, with a year-over-year increase of 26.3%. Net operating revenues rose 3.2% to $5.3 billion, driven by strong performance in Hospital Operations and Services and the Ambulatory Care segment.

  • Financial Outlook: The company revised its net operating revenue guidance for 2025 to between $21.15 billion and $21.35 billion, indicating a 2.8% growth from 2024. Adjusted EBITDA is expected to be between $4.47 billion and $4.57 billion, reflecting a 13% increase from the previous year.

  • Investor Sentiment: Despite recent positive earnings, estimates for Tenet have been trending downward, leading to a Zacks Rank of #3 (Hold). The stock has a strong Growth Score of A but a lower Momentum Score of D, indicating mixed investor sentiment.

  • Industry Comparison: Tenet is part of the Zacks Medical - Hospital industry, where competitor Universal Health Services reported a 13.4% revenue increase and has a Zacks Rank of #1 (Strong Buy), highlighting a contrasting performance within the sector.

[object Object]
Preview
4.5
11-25Benzinga
Stocks Surge as Nasdaq 100 Aims for Its Strongest Day in Six Months: What’s Driving Market Activity on Monday?

  • Market Rally Driven by Fed Expectations: Wall Street experienced a significant rally as traders increased bets on a Federal Reserve interest rate cut next month, following dovish comments from key officials, with a 77% chance now assigned to a 25-basis-point cut at the December meeting.

  • Tech Stocks Lead Gains: The Nasdaq 100 surged 2.4%, with semiconductor stocks like Broadcom and Micron leading the charge, while Alphabet's market cap surpassed Microsoft's, making it the third-largest publicly traded company.

  • Bitcoin and Commodities Performance: Bitcoin rose 0.5% to $87,000, indicating a pause in the recent selloff, while gold and silver also saw gains, with gold up 0.8% to $4,100 and silver up 1% to $50.50.

  • Major Indices and ETF Movements: The S&P 500 and Russell 2000 also posted gains, with the tech-heavy Invesco QQQ Trust rallying 2.3%, while the Consumer Staples Select Sector lagged behind, down 0.9%.

[object Object]
Preview
5.0
11-14SeekingAlpha
Eminence Capital Adds Tenet and Synopsys, Increases Holdings in SentinelOne and UNH in Q3 Adjustments

  • New Investments: Eminence Capital, led by Ricky Sandler, acquired new stakes in Tenet Healthcare (THC) and Synopsys (SNPS) during Q3 2025, along with additional investments in MongoDB (MDB) and Norwegian Cruise Line (NCLH).

  • Position Reductions: The fund reduced its holdings in SentinelOne (S) by nearly 70% and cut its position in UnitedHealth (UNH) by 31%, while also exiting investments in Amcor (AMCR), Freshworks (FRSH), and Sensient Technologies (SXT).

  • Increased Holdings: Eminence Capital significantly increased its stake in Jefferies Financial (JEF) to 3.4 million shares and raised its position in Coupang (CPNG) by 38% to 9.4 million class A shares.

  • Fund Overview: Founded in 1999, Eminence Capital manages approximately $7.8 billion in assets, with Ricky Sandler serving as the chief investment officer.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Tenet Healthcare Corp (THC) stock price today?

The current price of THC is 212.14 USD — it has increased 0.38 % in the last trading day.

arrow icon

What is Tenet Healthcare Corp (THC)'s business?

Tenet Healthcare Corporation is a diversified healthcare services company. The Company's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment is comprised of its acute care and specialty hospitals, a network of employed physicians and ancillary outpatient facilities. The Company's subsidiaries operate approximately 49 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 135 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency departments and micro hospitals. It also provides revenue cycle management and value based care services. The Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 518 ambulatory surgery centers, and 25 surgical hospitals in 37 states. The Company operates a Global Business Center in the Philippines.

arrow icon

What is the price predicton of THC Stock?

Wall Street analysts forecast THC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THC is 236.24 USD with a low forecast of 190.00 USD and a high forecast of 260.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Tenet Healthcare Corp (THC)'s revenue for the last quarter?

Tenet Healthcare Corp revenue for the last quarter amounts to 5.29B USD, increased 3.26 % YoY.

arrow icon

What is Tenet Healthcare Corp (THC)'s earnings per share (EPS) for the last quarter?

Tenet Healthcare Corp. EPS for the last quarter amounts to 3.86 USD, decreased -21.06 % YoY.

arrow icon

What changes have occurred in the market's expectations for Tenet Healthcare Corp (THC)'s fundamentals?

The market is revising Upward the revenue expectations for Tenet Healthcare Corporation (THC) for FY2025, with the revenue forecasts being adjusted by 0.44% over the past three months. During the same period, the stock price has changed by 8.14%.
arrow icon

How many employees does Tenet Healthcare Corp (THC). have?

Tenet Healthcare Corp (THC) has 74480 emplpoyees as of December 05 2025.

arrow icon

What is Tenet Healthcare Corp (THC) market cap?

Today THC has the market capitalization of 18.64B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free